Showing results (241-250 of 358) with videos related to

Sort By:
Pageof 36
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 2, 2010
Performance evaluation of the new ADVIA Centaur system cyclosporine assay (single-step extraction)Steven J Soldin, Robert W Hardy, Frank H Wians, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2016
Optimization of isoxazoline amide benzoxaboroles for identification of a development candidate as an oral long acting animal ectoparasiticideYong-Kang Zhang, Jacob J Plattner, Eric E Easom, et al.
Oncoimmunology|June 7, 2018
Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2Na Luo, Luigi Formisano, Paula I Gonzalez-Ericsson, et al.
Annals of Medicine|October 13, 2025
Spatial immunoprofiling of retroperitoneal leiomyosarcomas reveals intratumoral heterogeneity in immune cell infiltration, checkpoint molecule expression, and tertiary lymphoid structuresIva Benesova, Jan Balko, Vira Tovazhnianska, et al.
Journal of Visualized Experiments : Jove|April 12, 2021
Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content TissuesCharles A Havnar, Oliver Zill, Jeff Eastham, et al.
The Journal of Biological Chemistry|October 13, 2006
Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factorLuigi Notari, Victoriano Baladron, J Daniel Aroca-Aguilar, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2011
The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epitheliumJustin M Balko, Todd W Miller, Meghan M Morrison, et al.
Circulation. Heart Failure|October 8, 2009
Association of cystatin C with left ventricular structure and function: the Dallas Heart StudyParag C Patel, Colby R Ayers, Sabina A Murphy, et al.
Biomaterials|May 7, 2026
A molecularly defined polymeric platform for environmentally responsive activation of STING to enhance cancer immunotherapyJacob A Schulman, Karan Arora, Alexander J Kwiatkowski, et al.
Cancer Research|May 2, 2013
Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signalingChristian D Young, Adam D Pfefferle, Philip Owens, et al.
Pageof 36